Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Boston Scientific | 46 | 0 | 10 | 0 | €68.50 | €73.05 | 6.638% |
| Stryker Corp. | 23 | 0 | 7 | 0 | €306.90 | €335.03 | 9.165% |
| Vertex Pharmaceuticals Inc. | 45 | 2 | 7 | 0 | €392.60 | €406.87 | 3.634% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €205.70 | €294.01 | 42.932% |
| Amgen Inc. | 25 | 0 | 6 | 0 | €287.90 | €297.31 | 3.269% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 5 | 1 | €903.60 | €957.22 | 5.934% |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | €156.94 | €200.06 | 27.474% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €61.21 | €86.77 | 41.760% |
| Eli Lilly Corp. | 50 | 0 | 5 | 0 | €705.70 | €766.92 | 8.674% |
| HCA Holdings Inc. | 22 | 0 | 5 | 0 | €303.20 | €303.80 | 0.197% |
| Align Technology | 15 | 2 | 4 | 0 | €252.30 | €345.95 | 37.119% |
| Hologic Inc. | 17 | 0 | 4 | 0 | €70.00 | €84.52 | 20.744% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.20 | €174.43 | 16.913% |
| Thermo Fisher Scientific Inc. | 26 | 0 | 4 | 0 | €550.70 | €568.09 | 3.158% |